CA
NZ
UK
AU
IND
US
A Form 4 filed on August 25, 2026, disclosed that Waters S. Davis IV, a director of Targa Resources Corp. (NYSE:TRGP), sold 2,400 shares of common stock across six tranches on August 21, 2026.
Stephen J. Hill, Chief Operating Officer of Lyell Immunopharma, Inc., filed a statement of changes in beneficial ownership on August 25, 2026, reporting a sale of common stock on August 21, 2026, related to the settlement of vested restricted stock units.
A Form 4 filed with the SEC on August 25, 2026, discloses that J Thomas Hill, a director of Vulcan Materials CO (NYSE:VMC), sold a total of 14,000 shares of common stock on August 21, 2026, across four separate transactions.
Gary K. Lee, Chief Scientific Officer of Lyell Immunopharma, Inc., filed a Form 4 on August 25, 2026, disclosing an automatic sale of common stock on August 21, 2026, to satisfy tax withholding obligations arising from the settlement of vested restricted stock units.
Marcos Marcelo Mindlin, a director and 10% owner of Pampa Energy Inc., filed a Form 4 on August 25, 2026, disclosing the purchase of 675,000 shares of common stock on August 21, 2026.
A Form 4 filed with the SEC on August 25, 2026 discloses that Jacob Steven Leach, President, CEO, and Director of DexCom Inc (NASDAQ:DXCM), had 1,451 shares of common stock withheld on August 22, 2026 to cover tax obligations related to the net settlement …
A Form 4 filed with the SEC on August 25, 2026 reports that Alejandro Raul Scannapieco, a director of VTEX (NYSE:VTEX), sold 11,994 Class A Common Shares on August 24, 2026 at a weighted average price of $3.67 per share.
Michael Jon Brown, Executive Vice President and Chief Legal Compliance Officer of DexCom Inc (NASDAQ:DXCM), filed a Form 4 on August 25, 2026, reporting a transaction dated August 22, 2026, involving the withholding of common shares to cover tax obligations upon the net settlement …
Jereme M. Sylvain, Executive Vice President and Chief Financial Officer of Dexcom Inc (NASDAQ:DXCM), filed a Form 4 on August 25, 2026, disclosing a transaction in company common stock dated August 22, 2026.
A Form 4 filed with the SEC on August 25, 2026 discloses that Rajesh Kalathur, a director of American Tower Corp /MA/, purchased 2,829 shares of common stock on August 21, 2026.
Please wait processing your request...